Altria Group, Inc. (MO)
Altria: Enjoy The Last Puff -- Strong Sell
Altria (MO) is rated strong sell due to deteriorating fundamentals and an overvalued stock price. MO's premium Marlboro volumes crashed 12.6% in Q4, with overall cigarette volumes declining faster than the industry. Smokeless segment growth is insufficient to offset steep declines in the core cigarette business, with on! losing market share in Q4.
Altria 2025 Earnings: Moving Beyond Smoking? Don't Hold Your Breath
U.S.-focused tobacco company Altria Group, Inc. reported its results for the fourth quarter and full-year 2025 yesterday. Altria remains a premium cigarette powerhouse, delivering extremely robust profitability despite a 10% decline in cigarette shipments and persistent smoke-free segment weakness. MO's pricing power and operational efficiency drove all-time high adjusted operating margin, with price elasticity still very manageable and Marlboro retaining a dominant 59.2% share in the premium segment.
Altria's Q4 Earnings Lag Estimates, Cigarette Volumes Drop
MO's fourth-quarter results miss earnings estimates as cigarette volumes slid, with smokeable revenue declines weighing on profits despite pricing gains.
Altria Group, Inc. (MO) Q4 2025 Earnings Call Transcript
Altria Group, Inc. (MO) Q4 2025 Earnings Call Transcript
Compared to Estimates, Altria (MO) Q4 Earnings: A Look at Key Metrics
While the top- and bottom-line numbers for Altria (MO) give a sense of how the business performed in the quarter ended December 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Altria (MO) Lags Q4 Earnings Estimates
Altria (MO) came out with quarterly earnings of $1.3 per share, missing the Zacks Consensus Estimate of $1.32 per share. This compares to earnings of $1.29 per share a year ago.
Altria Profit Falls as Cigarette Sales Decline
Altria reported lower fourth-quarter profit as cigarette shipment volume declined, dragging down its smokeable product business.
Altria's Q4 Earnings on the Deck: How to Play the Stock
MO's fourth-quarter results are likely to reflect pricing strength and cost discipline, offsetting ongoing cigarette volume pressure.
Altria Expands Beyond Nicotine: Is MO's Strategy Worth Watching?
MO is evaluating non-nicotine and wellness categories through a KT&G collaboration as part of a long-term effort to diversify beyond tobacco.
Insights Into Altria (MO) Q4: Wall Street Projections for Key Metrics
Get a deeper insight into the potential performance of Altria (MO) for the quarter ended December 2025 by going beyond Wall Street's top-and-bottom-line estimates and examining the estimates for some of its key metrics.
Altria (MO) Surpasses Market Returns: Some Facts Worth Knowing
In the closing of the recent trading day, Altria (MO) stood at $61.91, denoting a +1.44% move from the preceding trading day.
Altria (MO) Reports Next Week: Wall Street Expects Earnings Growth
Altria (MO) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
